Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 2
2014 5
2015 4
2016 3
2017 3
2018 3
2019 3
2020 4
2021 2
2022 4
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Active surveillance versus treatment in low-risk DCIS: Women's preferences in the LORD-trial.
Schmitz RSJM, Engelhardt EG, Gerritsma MA, Sondermeijer CMT, Verschuur E, Houtzager J, Griffioen R, Retèl V, Bijker N, Mann RM, van Duijnhoven F, Wesseling J, Bleiker EMA; Grand Challenge PRECISION Consortium. Schmitz RSJM, et al. Among authors: engelhardt eg. Eur J Cancer. 2023 Oct;192:113276. doi: 10.1016/j.ejca.2023.113276. Epub 2023 Aug 4. Eur J Cancer. 2023. PMID: 37657228 Free PMC article.
Prediction Models and Decision Aids for Women with Ductal Carcinoma In Situ: A Systematic Literature Review.
Schmitz RSJM, Wilthagen EA, van Duijnhoven F, van Oirsouw M, Verschuur E, Lynch T, Punglia RS, Hwang ES, Wesseling J, Schmidt MK, Bleiker EMA, Engelhardt EG, Grand Challenge Precision Consortium. Schmitz RSJM, et al. Among authors: engelhardt eg. Cancers (Basel). 2022 Jul 2;14(13):3259. doi: 10.3390/cancers14133259. Cancers (Basel). 2022. PMID: 35805030 Free PMC article. Review.
De-ESCAlating RadioTherapy in breast cancer patients with pathologic complete response to neoadjuvant systemic therapy: DESCARTES study.
van Hemert AKE, van Olmen JP, Boersma LJ, Maduro JH, Russell NS, Tol J, Engelhardt EG, Rutgers EJT, Vrancken Peeters MTFD, van Duijnhoven FH. van Hemert AKE, et al. Among authors: engelhardt eg. Breast Cancer Res Treat. 2023 May;199(1):81-89. doi: 10.1007/s10549-023-06899-y. Epub 2023 Mar 9. Breast Cancer Res Treat. 2023. PMID: 36892723
Psychological impact of referral to an oncology hospital on patients with an ovarian mass.
Lof P, Engelhardt EG, van Gent MDJM, Mom CH, Rosier-van Dunné FMF, van Baal WM, Verhoeve HR, Hermsen BBJ, Verbruggen MB, Hemelaar M, van de Swaluw JMG, Knipscheer HC, Huirne JAF, Westenberg SM, van Driel WJ, Bleiker EMA, Amant F, Lok CAR. Lof P, et al. Among authors: engelhardt eg. Int J Gynecol Cancer. 2022 Dec 13:ijgc-2022-003753. doi: 10.1136/ijgc-2022-003753. Online ahead of print. Int J Gynecol Cancer. 2022. PMID: 36600495
Sexual functioning more than 15 years after premenopausal risk-reducing salpingo-oophorectomy.
Terra L, Beekman MJ, Engelhardt EG, Heemskerk-Gerritsen BAM, van Beurden M, Roeters van Lennep JE, van Doorn HC, de Hullu JA, Van Dorst EBL, Mom CH, Slangen BFM, Gaarenstroom KN, van der Kolk LE, Collée JM, Wevers MR, Ausems MGEM, Van Engelen K, van de Beek I, Berger LPV, van Asperen CJ, Gomez Garcia EB, Maas AHEM, Hooning MJ, Aaronson NK, Mourits MJE, van Leeuwen FE. Terra L, et al. Among authors: engelhardt eg. Am J Obstet Gynecol. 2023 Apr;228(4):440.e1-440.e20. doi: 10.1016/j.ajog.2022.11.1289. Epub 2022 Nov 17. Am J Obstet Gynecol. 2023. PMID: 36403862 Free article.
Disclosing the Uncertainty Associated with Prognostic Estimates in Breast Cancer.
Engelhardt EG, Pieterse AH, Han PK, van Duijn-Bakker N, Cluitmans F, Maartense E, Bos MM, Weijl NI, Punt CJ, Quarles van Ufford-Mannesse P, Sleeboom H, Portielje JE, van der Hoeven KJ, Woei-A-Jin FJ, Kroep JR, de Haes HC, Smets EM, Stiggelbout AM. Engelhardt EG, et al. Med Decis Making. 2017 Apr;37(3):179-192. doi: 10.1177/0272989X16670639. Epub 2016 Sep 29. Med Decis Making. 2017. PMID: 27681991
Preferences of Treatment Strategies among Women with Low-Risk DCIS and Oncologists.
Byng D, Retèl VP, Engelhardt EG, Groothuis-Oudshoorn CGM, van Til JA, Schmitz RSJM, van Duijnhoven F, Wesseling J, Bleiker E, van Harten WH, On Behalf Of The Grand Challenge Precision Consortium. Byng D, et al. Among authors: engelhardt eg. Cancers (Basel). 2021 Aug 6;13(16):3962. doi: 10.3390/cancers13163962. Cancers (Basel). 2021. PMID: 34439126 Free PMC article.
29 results